GLS and ovarian carcinoma: Consistent with this, we demonstrated that the effective inhibition of c-Myc with 10058-F4 in human ovarian cancer cell lines correlated with reduced glutaminase and ASCT-2 protein levels and subsequently reduced radiolabeled glutamine uptake.